SCHEMBL19488325

SCHEMBL19488325

CCCN(Cc1nc2cc(-c3cnc(-c4ccc(C)c(NC(=O)OC(C)(C)C)c4)o3)ccc2[nH]1)C(=O)[C@@H](c1ccccc1)N(C)C

nearest known ligand 0.34

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 9/20 0.34
▸ TP53 P04637 6/20 0.34
▸ SMN1; SMN2 Q16637 3/20 0.34
▸ THRB P10828 2/20 0.34
▸ KDM4E B2RXH2 2/20 0.33
▸ PTPN1 P18031 1/20 0.32
▸ ALDH1A1 P00352 2/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32
▸ ELANE P08246 1/20 0.31
▸ CTRB1 P17538 1/20 0.31
▸ CACNA1G O43497 1/20 0.31
▸ LMNA P02545 1/20 0.31
▸ NTRK1 P04629 1/20 0.31
▸ CKS1B P61024 1/20 0.31
▸ SKP1 P63208 1/20 0.31
▸ SKP2 Q13309 1/20 0.31
▸ PIN1 Q13526 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19488879 0.87 MAPT (0.33) MAPTTP53SMN1; SMN2THRBKDM4E
SCHEMBL19488331 0.86 KDM4E (0.33) MAPTTP53SMN1; SMN2KDM4EALDH1A1
SCHEMBL19488335 0.86 DHODH (0.32) MAPTTP53SMN1; SMN2THRBKDM4E
SCHEMBL19488857 0.85 MAPT (0.34) MAPTTP53SMN1; SMN2THRBKDM4E
SCHEMBL19488884 0.82 ALDH1A1 (0.39) MAPTTP53SMN1; SMN2KDM4EALDH1A1
SCHEMBL19488332 0.80 LMNA (0.42) MEN1KMT2ANPSR1LMNA
SCHEMBL19488649 0.79 MAPT (0.33) MAPTTP53SMN1; SMN2THRBKDM4E
SCHEMBL12403413 0.78 PRCP (0.40) —
SCHEMBL19488324 0.77 KIT (0.33) MAPTTP53SMN1; SMN2THRB
SCHEMBL19488859 0.76 LMNA (0.48) KDM4EALDH1A1MEN1KMT2ANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2601188-B1 HEPATITIS C VIRUS INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2017-10-18 — — EP disclosed
Send feedback